ClinicalTrials.Veeva

Menu

Digital Mindfulness for Young Adults With Type 1 Diabetes

Yale University logo

Yale University

Status

Not yet enrolling

Conditions

Diabetes Secondary to Pancreatitis
Type 1 Diabetes (T1D)

Treatments

Behavioral: Mindfulness app

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT07062887
2000039191

Details and patient eligibility

About

The purpose of this research study is to test a mindfulness app called Calm Health among young adults with type 1 diabetes or other absolute insulin deficiency diabetes. Mindfulness is the practice of being aware of your thoughts and feelings in the moment without judgment or negative reaction. All participants will receive mindfulness guidance and personalized feedback about the relationship among your mindfulness, blood sugar, stress, and sleep.

Enrollment

10 estimated patients

Sex

All

Ages

18 to 30 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Receiving diabetes care at Yale New Haven Children's Hospital or Yale New Haven Hospital.
  2. Sign and date informed consent form we will provide
  3. Willingness to complete procedures and availability for duration of the study
  4. Aged 18-30 years
  5. Diagnosed with type 1 diabetes (T1D) or other absolute insulin deficiency diabetes (latent autoimmune diabetes of adulthood, diabetes secondary to pancreatitis) for at least 1 year.
  6. User of a continuous glucose monitor (CGM) in your routine clinical care for at least the past 2 weeks.
  7. Able to use a smartphone.
  8. Able to read and write English.

Exclusion criteria

  1. Current meditation or mindfulness practice meeting or exceeding the study's recommended schedule
  2. Current severe untreated psychiatric illness (e.g., bipolar disorder, schizophrenia, major depression, panic disorder, borderline personality disorder, organic mood or mental disorders) or active suicidal ideation
  3. New or unstable psychopharmaceutical treatment in past 2 months.
  4. Current or planned pregnancy during study period.

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

10 participants in 1 patient group

Mindfulness App
Experimental group
Description:
Use the mindfulness app for 6 weeks, wear an actigraphy watch, share the data from your own continuous glucose monitor (CGM), answer surveys and interviews about the app.
Treatment:
Behavioral: Mindfulness app

Trial contacts and locations

1

Loading...

Central trial contact

Garrett I Ash, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems